BioGaia AB (BGLAF)

Overview

BioGaia AB (publ) is a recognized healthcare company that operates globally, focusing on the delivery of probiotic products. Established in 1990 and headquartered in Stockholm, Sweden, the company engages in developing and distributing a variety of probiotic solutions tailored for both pediatric and adult healthcare needs. BioGaia's operations are segmented into Pediatrics, Adult Health, and Other, each offering specialized products designed to improve gut health and overall well-being. The company’s strategy involves reaching its customers through partnerships with distributors or leveraging its distribution networks, ensuring a wide accessibility of its health-promoting products across different regions.

Products and Services

• Pediatrics Products:

  The Pediatrics segment is dedicated to enhancing the health of infants and young children through probiotic products such as drops, oral rehydration solutions (ORS), and gut health tablets. Additionally, this segment supplies cultures used in the manufacturing of infant formulas. These products aim to support the development of a healthy gut flora in children, contributing to their overall growth and well-being.

• Adult Health Products:

  Focusing on the wellbeing of adults, this segment offers gut health tablets and oral health lozenges. Furthermore, BioGaia provides probiotic cultures used as ingredients in dairy products distributed by licensees. These items are designed to aid in maintaining a balanced digestive system and promote oral health, reflecting the company's commitment to enhancing quality of life through probiotics.

• Other Services:

  Apart from its core product lines focused on healthcare, BioGaia also engages in providing packaging solutions, demonstrating its capability to deliver comprehensive services that go beyond probiotics. This segment caters to various needs by offering innovative and sustainable packaging options, further illustrating BioGaia’s commitment to versatility and customer satisfaction.